Company intelligence / Profile preview
Sparian Biosciences
New York City, New York, United Statessparianbiosciences.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Sparian Biosciences is a clinical-stage CNS-focused biopharmaceutical company developing novel small molecule therapies for pain, substance use disorders, and the opioid crisis. Its lead asset SBS‑226 is a first-in-class dual mu opiate receptor partial agonist and delta opiate receptor full antagonist in development for opioid use disorder and withdrawal syndrome. The company has received significant NIH/NIDA funding and collaborates with leading academic institutions. Early clinical data suggest efficacy in reducing opiate-induced withdrawal without precipitating withdrawal symptoms seen with current standards of care.
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- Small moleculeChemical drug
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
National Institutes of Health / National Institute on Drug Abuse (NIH/NIDA)U.S. Army Institute of Surgical Research/Department of DefenseMemorial Sloan Kettering Cancer CenterRutgers University Medical SchoolUSC Michelson Center for Convergent BioscienceWashington UniversityUniversity of Florida
Beyond the preview
Go deeper on Sparian Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sparian Biosciences.